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UV Signaling Pathways within the Skin
Hongxiang Chen1,2,3, Qing Y. Weng1,3 and David E. Fisher1
The effects of UVR on the skin include tanning,
carcinogenesis, immunomodulation, and synthesis of
vitamin D, among others. Melanocortin 1 receptor
polymorphisms correlate with skin pigmentation, UV
sensitivity, and skin cancer risk. This article reviews
pathways through which UVR induces cutaneous
stress and the pigmentation response. Modulators of
the UV-tanning pathway include sunscreen agents,
melanocortin 1 receptor activators, adenylate cyclase
activators, phosphodiesterase 4D3 inhibitors, T-oligos,
and microphthalmia-associated transcription factor
regulators such as histone deacetylase inhibitors.
UVR, as one of the most ubiquitous carcinogens,
represents both a challenge and an enormous oppor-
tunity in skin cancer prevention.
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INTRODUCTION
The incidence of melanoma and non-melanoma skin cancers
has continued to rise over the past few decades. The etiology
is multifactorial with discrete genetic pathways and environ-
mental factors. Although genetic factors may contribute sig-
nificantly, environmental factors can be modified to
potentially decrease the risk of developing deadly diseases
such as melanoma. Exposure to UVR from sunlight is well
established as a significant risk factor for melanoma develop-
ment. However, indoor tanning is a source of preventable
UVR exposure that represents a growing, multi-billion dollar
industry (Levine et al., 2005). UVR is a major environmental
risk factor that contributes to carcinogenesis through DNA
damage and immune modulation via inflammatory and
immunosuppressive pathways (Tran et al., 2008; Liu and
Fisher 2010; D’Orazio et al., 2013; Weinstock 2013). It has
long been appreciated that tanning, through increasing
epidermal melanin content, is the skin’s major photo-
protective response against acute and chronic UV damage.
DNA damage from UVR induces signaling cascades that
ultimately lead to activation of pigmentation machinery to
produce the tanning effect. This process can be synthetically
perturbed at different points along the pathway to upregulate
driver signals or to suppress inhibitory feedback, thereby
promoting a UVR-independent protective tanning response.
These strategies range from broad, such as transcriptional
activators, to narrow, such as molecular analogs. Because the
UV-tanning pathway is essential for both melanogenesis and
protection from skin cancers, we summarize here the
consequences of the UV signaling pathway deficiencies and
strategies to regulate the the UV signaling pathway.
FEATURES OF UVR AND UV-INDUCED MUTAGENESIS
UVR, spanning the 200 to 400 nm wavelengths of the
electromagnetic spectrum, is a high-energy component of
solar radiation. UVR is divided into three categories based
on wavelength: UVA (400–320 nm), UVB (320–290 nm), and
UVC (290–200 nm). Over 95% of UVA and 1–10% of UVB
radiation reaches the earth’s surface, whereas almost 100% of
solar UVC is absorbed by the atmosphere and the ozone layer.
Thus, most of the research on the effects of UVR has focused
on UVA and UVB. A history of sunburn in childhood and
continued unprotected exposure to UVR through adolescence
and adulthood contribute to skin cancer risk. However, many
adolescents and adults continue to seek a tan, either from
direct sun exposure or from tanning beds.
UVR directly targets macromolecules in the skin such as
proteins, lipids, and nucleic acids, with the latter resulting in
signature mutations characteristically found in melanomas
and other skin cancers. When these mutations occur within
genes regulating apoptosis, cell cycle progression, and genetic
repair machinery, they may initiate oncogenic transformation
(Schulman and Fisher 2009; Fisher and James 2010). UVR
photoexcitation of the direct chromophore DNA produces
excited electron states and toxic by-products, leading to direct
and indirect DNA damage. This often produces signature
mutations dependent on the insult and mechanism of damage.
We will focus on mutations resulting from UVA and UVB
specifically.
UVA radiation, upon exciting endogenous chromophores,
can generate reactive oxygen species capable of causing
oxidative DNA damage. Through generation of singlet oxygen
(1O2) or type-1 photosensitization reactions, UVA is able to
cause oxidative base modifications, predominately at guanine
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bases. This process leads to generation of 7,8-dihydro-8-
oxoguanine lesions, which have been shown to induce
specific DNA mutations if not repaired. (Garibyan and
Fisher 2010).The major UVA-induced mutations are G-T
transversions and G-A transitions. Like UVB, UVA may also
trigger DNA damage through cyclobutane pyrimidine dimer
(CPD) formation.
UVB contact with DNA activates a photochemical reaction
that usually occurs between adjacent pyrimidine nucleotides
and leads to formation of photoproducts known as CPDs and
pyrimidine 6-4 pyrimidones. After the formation of CPDs and
pyrimidine 6-4 pyrimidone photoproducts, either spontaneous
reversion may occur (for CPDs), or DNA repair enzymes
participate in the correction of the damage. Incorrect repair of
these damaged DNA lesions leads to mutations in epidermal
cells that may initiate oncogenesis. When UVB-induced CPDs
and pyrimidine 6-4 pyrimidones are incorrectly resolved,
certain signature mutations may form, including C-T and
CC-TT transition mutations (Tran et al., 2008; Garibyan and
Fisher 2010).
These characteristic mutations are not exclusively induced
by UVR from sunlight. DeMarini and colleagues compared the
mutagenic effects of radiation from three common sources
using Salmonella assays and determined that mutagenic ability
was most potent in radiation from tanning salon beds,
followed by sunlight. White fluorescent light represented the
least mutagenic source of radiation. The most common
mutations were G:C-A:T transitions. The CC-TT transitions
characteristic of UVB exposure represented 83% of mutations
induced by tanning bed radiation exposure, demonstrating
that both solar and non-solar sources of UV radiation are
capable of inflicting signature UV mutations (DeMarini et al.,
1995; Besaratinia and Pfeifer 2008).
Although UVB mutations have comprised the majority of
the traditional UVR-associated mutations, little overlap exists
between these mutations and those observed in codon V600
of the BRAF gene, the most common location of the well-
established BRAF mutations in melanoma. BRAF V600 var-
iants can be attributed to G-A transitions and T-A, T-G,
and G-T transversions (Thomas et al., 2006; Besaratinia
and Pfeifer 2008). In contrast, traditional UVB-induced
mutations from exposure to sunlight are characterized by
single or tandem C-T transitions at dipyrimidine nucleotides.
Damage from UVA radiation has been characterized more
recently, with one mechanism being the generation of DNA
cross-links and lesions through oxidative damage from UVA-
induced photosensitization reactions. Certain of these UVA-
induced DNA lesions resemble mutations in BRAF V600
variants from sun-exposed melanomas, suggesting a greater
role for UVA in melanomagenesis than traditionally thought
(Garibyan and Fisher 2010). Importantly, BRAF V600
mutations may also occur in non-sun-exposed malignancies,
such as colon, lung, and thyroid, potentially consistent with
oxidative damage as a common carcinogenic mechanism
(in those cases independent of UVA). Other important
melanoma-associated genes such as INK4A, PTEN, FGFR2,
and N-RAS may also possess mutations attributable to UVR
(Mar et al., 2013).
UV SIGNALING PATHWAYS FOR TANNING
The core component of the skin response to sunlight is the
epidermal melanin unit, comprised of the melanocyte and its
associated keratinocytes. UV exposure induces DNA damage
in keratinocytes and results in stabilization of the p53 tumor
suppressor protein. This promotes p53 transcriptional activa-
tion of proopiomelanocortin, which is enzymatically cleaved
to produce a–melanocyte-stimulating hormone (a-MSH). a-
MSH is released by keratinocytes and binds the MC1R on
melanocytes. MC1R activation by a-MSH triggers an increase
in cAMP levels within the melanocytes, which increase
transcription of microphthalmia-associated transcription
factor (MITF) via CRE-binding protein/activating transcription
factor 1. Binding of MITF to the E-box sequences in promoter
regions triggers transcription of numerous pigmentation genes
(Tran et al., 2008; Hearing, 2011a,b). These genes act to
synthesize, mature, and traffic melanin, the most common
types of which are brown-black eumelanin and yellow-red
pheomelanin. The melanin is packaged in melanosomes
which are exported to keratinocytes, where they localize
over the nucleus and may protect the genomic material from
further UVR-induced damage (Figure 1 and Figure 2).
CONSEQUENCES OF UV SIGNALING PATHWAY
DEFICIENCY
The loss of p53
As an important regulator of the genotoxic response, p53 is a
key tumor suppressor gene that is mutated frequently in

































Figure 1. The epidermal melanin unit and tanning response to UV radiation.
UV radiation induces DNA damage, which leads to activation of p53. In turn,
p53 stimulates transcriptional upregulation of the proopiomelanocortin
(POMC) gene, which is posttranslationally processed to adrenocorticotrophic
hormone (ACTH), a-melanocyte-stimulating hormone (a-MSH), and
b-endorphin. Secreted a-MSH binds to the melanocortin 1 receptor (MC1R) on
melanocytes, leading to production of melanin. The melanin is packaged
within melanosomes and transported back to keratinocytes, where they
localize over the nucleus as part of the protective tanning response to UV
radiation.
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regulates multiple signaling pathways in response to stimuli
such as DNA damage, oxidative stress, hypoxia, heat shock,
membrane compromise, and other stresses (Cui et al., 2007).
p53 is thought to participate in DNA repair via multiple
mechanisms, including control of cell cycle checkpoint
activity as well as regulation of the DNA repair machinery.
Lesions with mutant p53 are readily found in UV-exposed
hairless mouse skin and sun-exposed healthy human skin.
These mutations tend to be localized to dipyrimidine
sequences and consist of C-T or CC-TT transitions
(Beaumont et al., 2008; Weinstock 2013).
MC1R mutations in skin cancers
The MC1R gene is highly polymorphic in humans, with over
80 variants identified. Certain variants are closely associated
with red hair color (RHC) phenotype, which is accompanied
by fair skin, poor tanning ability, high sunburn risk, and the
highest risk of melanoma for any skin pigmentation type. Other
MC1R polymorphic variants with weaker melanoma associa-
tions are known as ‘‘non-red hair color’’ variants. Three RHC
variants of MC1R that are associated with fair skin and poor
tanning are Arg151Cys, Arg160Trp, and Asp294His (Han et al.,
2006). The 151Cys variant was associated with increased risks
of the three types of skin cancer after controlling for hair color,
skin color, and other skin cancer risk factors. Women with
medium or olive skin color carrying one non-red hair color
allele and one red hair color allele had the highest risk of
melanoma (Han et al., 2006; Fargnoli et al., 2010).
One mechanism by which MC1R polymorphisms affect
melanoma risk may be through repair of DNA damage
(Kadekaro et al., 2005). Human melanocyte cultures
exposed to varying levels of UVR were found to have CPD
levels that correlated with MC1R genotype and function. In
the melanocytes with non-functional MC1R, treatment with
forskolin to directly activate adenylate cyclase appeared to
enhance CPD repair (Hauser et al., 2006).
Eumelanin and pheomelanin synthesis contributes to
melanomagenesis
In addition to its direct effects on DNA damage repair, MC1R
may also affect oncogenic drivers through regulation of
pigmentation. MC1R signaling and cysteine availability gov-
ern the balance in production of eumelanin and pheomelanin.
The amino acid cysteine is required for pheomelanin synthesis
but not eumelanin synthesis. When MC1R signaling is strong,
cysteine stores are insufficient to keep pace with the rate of
generation of pigment precursors, and eumelanin production




































Figure 2. Melanin synthesis and strategies to regulate the tanning response. Secreted a-melanocyte-stimulating hormone (a-MSH) from keratinocytes binds
melanocortin 1 receptor (MC1R) on melanocytes, leading to upregulation of cAMP, which stimulates expression of microphthalmia-associated transcription factor
(MITF). MITF then transcriptionally activates expression of enzymatic machinery including tyrosinase and tyrosinase-related protein 1 (Tyrp1), which are critical in
the synthesis of melanin within melanosomes. Tyrosinase catalyzes the initial conversion of tyrosine to dihydroxyphenylalanine (DOPA) and dopaquinone.
Dopaquinone may then combine with cysteine to form the pheomelanin precursor cysteinyldopa, or it may enter a separate pathway catalyzed in part by Tyrp1 to
produce the eumelanin precursor. The matured melanin is then transported in vesicles called melanosomes to the overlying epidermal keratinocytes. Strategies
such as MC1R activators, adenylate cyclase activators, phosphodiesterase 4D3 inhibitors, and MITF regulators are shown to regulate the UV-tanning response by
targeting different components of this pathway.
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melanocytes, cysteine stores keep pace with the slower
formation of pigment precursors, leading to formation of
cysteine-containing pheomelanin. In our 2012 study using
redhead mice with inactivating MC1R mutations, UVR was
not necessary for increased melanoma development in these
mice when compared with black mice expressing an activat-
ing BRAF mutation in their melanocytes. This study supports
carcinogenic potential of the pheomelanin synthetic pathway
through an UVR-independent mechanism.
Oxidative stress appeared to have a role in pheomelanin-
mediated melanomagenesis (Mitra et al., 2012). We hypo-
thesize two possible mechanistic pathways to explain the
observed pheomelanin-dependent oxidative DNA damage
that drives melanomagenesis. First, pheomelanin might
generate reactive oxygen species that directly or indirectly
cause oxidative DNA damage. Second, pheomelanin synthesis
might consume cellular antioxidant stores and make the cell
more vulnerable to other endogenous reactive oxygen species
(Morgan et al., 2013).
STRATEGIES TO REGULATE THE PIGMENTATION
SIGNALING PATHWAY
The UV signaling pathway can be synthetically perturbed at
different points to regulate the activity of MC1R, adenylate
cyclase, cAMP, and MITF. Such strategies could induce a
UV-independent tanning response, potentially conferring a
photoprotective effect against UVR-mediated melanomagen-
esis. Here, we will discuss targetable processes at each level in
detail.
MC1R activators (analogs of a-MSH)
In addition to the use of sunscreen agents, one strategy for
melanoma prevention is based on analogs of a-MSH that func-
tion as MC1R agonists (Marwaha et al., 2005). These include
products such as melanotan I, melanotan II, afamelanotide,
Ac-His-D-Phe-Arg-Trp-NH2, and n-Pentadecanoyl- and
4-Phenylbutyryl-His-D-Phe-Arg-Trp-NH2. Those analogs were
more potent than a-MSH itself in stimulating melanogenesis,
as well as reducing apoptosis, decreasing release of hydrogen
peroxide, and enhancing repair of DNA photoproducts in
melanocytes exposed to UVR. The photoprotective and other
biological effects of a-MSH analogs await full determination
(Hadley et al., 1998; Langan et al., 2010; Miller and Tsao
2010; Schulze et al., 2013).
Some pathologic processes can alter levels of a-MSH and
indirectly affect melanogenesis. a-MSH, like ACTH and
thyroid-stimulating hormone, is secreted by the anterior
pituitary gland. In Addison’s disease (chronic adrenal insuffi-
ciency), lack of negative feedback from cortisol induces the
anterior pituitary to produce greater levels of ACTH. As a by-
product, more MSH is also produced, leading to hyperpig-
mented lesions in these patients. The classical hypothalamic-
pituitary-adrenal axis is a negative feedback neuroendocrine
pathway that is essential for the systemic response to external
or internal stress. Emerging evidence has indicated that a fully
functional cutaneous equivalent participates in the response of
skin to local stress as well as other homeostatic contexts
(Slominski and Wortsman 2000; Zbytek et al., 2006; Slominski
et al., 2000, 2007, 2012). This local system can modulate the
function of skin and follicular melanin units following UVR
exposure and maintain or restore immune privilege in hair
follicles. In the tanning pathway, the epidermal melanin unit
comprised of the keratinocyte and melanocyte can be
recognized as a functional equivalent of the hypothalamic-
pituitary-adrenal axis in the skin.
Adenylate cyclase activation
Another strategy to promote the tanning response is through
direct stimulation of adenylate cyclase activity downstream of
MC1R. UVR-induced tanning is defective in numerous
fair-skinned individuals, some of whom possess functional
disruption of the MC1R. Although UVR is capable of inducing
a-MSH production in keratinocytes, loss of MC1R function in
red-haired mouse models results in inability to produce a
tanning response upon UV exposure. However, pigmentation
can be rescued by topical application of the cAMP agonist
forskolin. This process can occur without UVR, demonstrating
that the pigmentation machinery is available despite the
absence of functional MC1R (D’Orazio et al., 2006).
Alternative strategies
cAMP is an ATP-derived secondary messenger that functions
in signal transduction for a variety of intracellular pathways.
Levels of cAMP are controlled by its production, catalyzed by
adenylate cyclase, and its hydrolysis, catalyzed by the phos-
phodiesterase class of enzymes. Phosphodiesterase 4D3 was
identified as a direct target of the MSH/cAMP/MITF pathway
(Khaled et al., 2010). Its activation creates a negative feedback
loop that induces refractoriness to chronic stimulation of the
cAMP pathway in melanocytes. This highlights a potent
mechanism controlling melanocyte differentiation that may
be amenable to pharmacologic manipulation (Khaled et al.,
2010). Telomere-related oligonucleotides also have shown
promise in augmenting the tanning pathway while bypassing
UV-stimulation to confer a protective effect on skin (Arad
et al., 2006). This strategy was born from an understanding of
telomeric-derived oligonucleotides as inducers of DNA repair
responses in melanocytes, as well as concomitant inducers of
melanogenesis (Atoyan et al., 2007; Gilchrest et al., 2009).
Regulation of MITF through direct targeting and modification of
posttranscriptional processes
Finally, strategies to regulate the tanning response may focus
on MITF, which is required for melanocyte development and
is an amplified oncogene in a fraction of human melanomas.
In addition to its control of critical pigmentation genes, MITF
also regulates target genes essential to cell cycle progression,
apoptosis, and differentiation (Levy et al., 2006). Therefore,
pharmacologic suppression of MITF is of potential interest in a
variety of clinical settings. However, MITF is not known to
contain intrinsic catalytic activity amenable to direct small-
molecule inhibition (Flaherty et al., 2012). An alternative
drug-targeting strategy is to identify and interfere with
lineage-restricted mechanisms required for MITF expression.
Multiple histone deacetylase inhibitor drugs potently suppress
MITF expression in melanocytes, melanoma, and clear cell
H Chen et al.
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sarcoma cells (which are sometimes pigmented). Although
histone deacetylase inhibitors may affect numerous cellular
targets, they have been shown to suppress skin pigmentation
upon topical application in mice (Yokoyama et al., 2008).
High throughput screens to identify additional small
molecules capable of modulating MITF activity are currently
being conducted in the authors’ lab, and candidate leads are
under development.
A germline missense substitution in MITF (Mi-E318K) was
found to occur in families with high incidences of melanoma in
Australia, United States, Great Britain, and France (Bertolotto
et al., 2011; Yokoyama et al., 2011). Codon 318 is located in a
small-ubiquitin-like modifier (SUMO) consensus site (PsiKXE),
(Miller et al., 2005) and Mi-E318K ablated that SUMOylation
event on MITF. The Mi-E318K mutation measurably increases
MITF’s transcriptional activity. An additional key posttrans-
lational modification on MITF is its phosphorylation by
mitogen-activated protein kinase (Hemesath et al., 1998),
which subsequently targets MITF for ubiquitination and pro-
teolysis (Wu et al., 2000). More recently, it was shown that
MITF is targeted by the de-ubiquitinase USP13, a theoretically
drug-able protease whose suppression results in strong
downregulation of MITF protein levels (Zhao et al., 2011).
Other MITF gene regulators and MITF gene co-factors
In addition to directly targeting MITF, potential strategies to
regulate the tanning response can target factors upstream of
MITF or genes that serve as co-factors for MITF. The peroxi-
some proliferator-activated receptor gamma coactivator pro-
teins PGC-1a and PGC-1b are key mediators of a-MSH
activation of MITF. PGC-1a and PGC-1b are stabilized
through a-MSH signaling via phosphorylation by protein
kinase A. The PGC-1 proteins subsequently activate MITF
transcription, and inhibition of the proteins blocks expression
of MITF and its target genes in the tanning pathway.
Recent studies in humans revealed polymorphisms in PGC-
1b that associated with ability to tan and protection against
melanoma (Shoag et al., 2013). YY1, which functions as both
a transcriptional repressor and activator, also cooperates with
melanocyte-specific isoform MITF to regulate the expression
of the piebaldism gene KIT and multiple additional pigmen-
tation genes (Li et al., 2012).
CONCLUSIONS
Tanning represents increased melanization of the epidermis
following UV exposure. The UV-tanning pathway is a DNA
damage-related stress and injury response. Targeting compo-
nents of the UV-tanning pathway through small molecules
such as a-MSH analogs may be one strategy to modulate skin
pigmentation. a-MSH analogs would likely be less potent on
the MC1R loss-of-function variants that are most frequently
found in melanoma patients, but they might still function. The
strategies targeting components downstream of MC1R show
potential in rescuing deficiencies of the UV-tanning pathway.
These include adenylate cyclase activators, phosphodiesterase
4D3 inhibitors, and telomere-derived oligonucleotides.
Additional interventions which may suppress key melanoma
survival factors include MITF regulators such as histone
deacetylase inhibitors and candidates from ongoing high
throughput screens for MITF regulators. Strategies may also
target MITF posttranscriptional modification processes such as
SUMO modification, dimerization, and ubiquitination/deubi-
quitination. Future mechanism-based studies of UVR are
needed to help completely elucidate molecular pathways
responsible for the carcinogenic effects of UVR on the
melanocyte lineage. We hope to develop better strategies to
regulate pigmentation and in doing so, identify further oppor-
tunities for prevention, early detection, and treatment of
melanoma.
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